Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

LTBP1 is a key regulator in diseases and a potential target for new treatments.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Activating mitophagy may help manage a key immune response involved in the hair loss condition alopecia areata.

S100A4 and NMIIA promote tumor growth in glioblastoma by enhancing blood vessel functions.

Scientists discovered two versions of a new human hair keratin gene.

Hedgehog signaling is crucial for hair development, cadherins affect cell adhesion, neutrophils play a role in skin lesions, and BP230 autoantibodies impact skin stability.

Tick bites can cause hair loss similar to alopecia areata, and baricitinib may help regrow hair.

c-Myc, Max, and Bin1 help hair follicle cells mature and die.

Metabolite 7 is a strong inhibitor for Alzheimer's disease management.

A new mutation in the ST14 gene broadens the understanding of ichthyosis-hypotrichosis syndrome.

QIA-64 software can measure straight wire lengths accurately but needs improvement for curved wires and width measurements.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Inositol and folic acid treatment significantly reduced hair loss and other symptoms in patients with androgenetic alopecia, but more research is needed for confirmation.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Immature blackbuck pancreas has underdeveloped goblet cells and similar Langerhans islets in both sexes.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.

Researchers found a new genetic mutation linked to a hair condition in a Japanese boy.

A rare biotin deficiency in an Iraqi family caused severe symptoms but was successfully treated with lifelong biotin.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

The boy's severe skin disorder is caused by two new mutations in his TGM1 gene.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Correct skin biopsy techniques are crucial to avoid misdiagnosis of skin diseases.